PYRIMIDINES AS NOVEL THERAPEUTIC AGENTS
    3.
    发明申请
    PYRIMIDINES AS NOVEL THERAPEUTIC AGENTS 有权
    吡咯烷酮作为新治疗药物

    公开(公告)号:US20100298336A1

    公开(公告)日:2010-11-25

    申请号:US12784975

    申请日:2010-05-21

    摘要: The present invention features compounds having the Formula (Ia) and (Ib) (e.g., a compound of any of Formulas ((Ia-2)-(Ia-21)), including other tautomers, stereoisomers, E/Z stereoisomers, prodrugs, pharmaceutically acceptable salts, and compositions thereof. The invention also features methods for treating or preventing pain (e.g., neuropathic pain), inflammation, or epilepsy in a patient by administering an effective amount of a compound of Formula (Ia) or (Ib). The invention also features a method for treating or preventing pain (e.g., neuropathic pain), inflammation, or epilepsy in a patient that includes administering to a patient in need thereof an effective amount of a compound of Formula (IIa) or (IIb) (e.g., a compound of any of Formulas ((IIa-2)-(IIa-6)). The compounds described herein (e.g., a compound of Formulas (Ia), (Ib), (IIa), or (IIb)) can also be used as anticonvulsants.

    摘要翻译: 本发明的特征在于具有式(Ia)和(Ib)的化合物(例如,式((Ia-2) - (Ia-21))中任一项的化合物,包括其它互变异构体,立体异构体,E / Z立体异构体, 本发明还涉及通过施用有效量的式(Ia)或(Ib)化合物来治疗或预防患者的疼痛(例如神经性疼痛),炎症或癫痫的方法, 本发明还涉及治疗或预防患者的疼痛(例如神经性疼痛),炎症或癫痫的方法,其包括向有需要的患者施用有效量的式(IIa)或(IIb)化合物, 本文所述的化合物(例如,式(Ia),(Ib),(IIa)或(IIb)的化合物可以是式((IIa-2) - (IIa-6) )也可以用作抗惊厥药。